Previous close | 91.69 |
Open | 91.24 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 90.45 - 91.74 |
52-week range | 80.60 - 104.32 |
Volume | |
Avg. volume | 1,403,027 |
Market cap | 114.423B |
Beta (5Y monthly) | 0.44 |
PE ratio (TTM) | 25.09 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 3.76 (4.10%) |
Ex-dividend date | 13 May 2024 |
1y target est | N/A |
The past five days have been a rollercoaster for Novavax investors, as the share price of the company skyrocketed by over 200% following the announcement of a major deal with French pharmaceutical giant Sanofi.
The latest investor updates on stocks that are trending on Tuesday.
Explore key financial updates and strategic developments from Fulcrum Therapeutics' first quarter earnings call.